Will Survivors of the First Year of the COVID-19 Pandemic Have Lower Mortality?

Link: https://crr.bc.edu/working-papers/will-survivors-of-the-first-year-of-the-covid-19-pandemic-have-lower-mortality/

Report: https://crr.bc.edu/wp-content/uploads/2022/08/wp_2022-10.pdf

Graphic:

Abstract:

The mortality burden of the COVID-19 pandemic was particularly heavy among older adults, racial and ethnic minorities, and those with underlying health conditions.  These groups are known to have higher mortality rates than others even in the absence of COVID.  Using data from the 2019 American Community Survey, the 2018 Health and Retirement Study, and the 2020 National Vital Statistics System, this paper estimates how much lower the overall mortality rate will be for those who lived through the acute phase of the early pandemic after accounting for this selection effect of those who died from COVID.  Such selection may have implications for life insurance and annuity premiums, as well as assessments of the financial standing of Social Security – if the selection is large enough to substantially alter projected survivor mortality.

The paper found that:

  • 10-year mortality rates, absent direct COVID deaths and long COVID, will likely be lower in 2021 than anticipated in 2019.
  • However, these differences are small, ranging from a decline of 0.4 percentage points for people in their 60s to 1 percentage point for those in their 90s.
  • The small difference is in spite of the fact that COVID mortality was, indeed, very selective, with mortality declines exceeding half the maximum possible declines, holding total COVID deaths constant, for every age group.

 
The policy implications of the findings are:

  • That declines in mortality due to COVID selection likely will not impact overall population mortality substantially enough to affect Social Security cost projections.
  • Any impact of selection effects on Social Security costs will likely be swamped by ongoing mortality increases directly attributable to acute and long COVID.

Author(s): Gal Wettstein, Nilufer Gok, Anqi Chen, Alicia H. Munnell

Publication Date: August 2022

Publication Site: Center for Retirement Research at Boston College

Social and Other Determinants of Life Insurance Demand

Link: https://www.soa.org/resources/research-reports/2022/determinants-life-insurance/

Report: https://www.soa.org/4a50aa/globalassets/assets/files/resources/research-report/2022/determinants-life-insurance.pdf

Graphic:

Excerpt:

The authors examine 19 factors to determine which were most closely linked to permanent and term life insurance premiums sold in the United States in 2020. With spatial regression analysis using multi-scale geographically weighted regression (MGWR) approach, the authors find the following 5 covariates to be the most statistically significant for and positively correlated with permanent insurance sold: household income, percentage of the population that is African American, education, health insurance, and Gini index (a statistical measure of wealth inequality). For term insurance sold, the 5 most significant covariates are household income, education, Gini index, percentage of households with no vehicles, and health insurance. Their relationships with term insurance sold are positive except for the percentage of households with no vehicles.

Author(s):

Wilmer Martinez
Kyran Cupido
Petar Jevtic
Jianxi Su

Publication Date: August 2022

Publication Site: SOA

Can the CDC Repair Its Reputation?

Link: https://knowledge.wharton.upenn.edu/article/can-the-cdc-repair-its-reputation/

Graphic:

Excerpt:

The Centers for Disease Control and Prevention must learn from the mistakes it made during the height of the COVID-19 pandemic if it wants to win back public trust, according to Wharton health care management professor Ingrid Nembhard.

She thinks CDC Director Rochelle Walensky is on the right path to do just that. Walensky, who was appointed by President Joe Biden in 2021, has announced a major overhaul to modernize the agency and get the public messaging right.

….

Nembhard is particularly hopeful about Walensky’s focus on changing the culture at the CDC. The infrastructure to conduct the science and disseminate the information is vital, but so is the culture. Reports have surfaced that paint the agency as clunky with a risk-averse culture.

“If you have all of the structures but nobody is speaking up, where are you?” Nembhard said. “You don’t have all the information that you need, and I think that’s been one of the realities that we’ve seen them having to deal with. You really do need to have your systems in place to be flexible, to be able to manage under ever-changing circumstances.”

Author(s): Angie Basiouny

Publication Date: 13 Sept 2022

Publication Site: Knowledge @ Wharton

2020-2021 Excess Deaths in the U.S. General Population by Age and Sex

Link: https://www.soa.org/resources/research-reports/2022/excess-death-us/

Full report: https://www.soa.org/4a55a7/globalassets/assets/files/resources/research-report/2022/excess-death-us.pdf

Graphic:

Excerpt:

The data used for this analysis was provided by the CDC as of August 17, 2022 and includes incurred deaths
by week, beginning on December 29, 2019 and going through July 2, 2022. For 2020, the CDC defines Week
1 as ranging from December 29, 2019 through January 4, 2020 and Week 52 as ranging from December 19,
2020 through December 26, 2020, so when reporting on 2020 results, this convention is used. The year
2021 begins on December 27, 2020 and runs through January 2, 2022. For the purposes of this analysis, the
start of the COVID-19 active period is March 22, 2020.
Due to the delay in reporting, the actual deaths have been completed based on factors that vary by age
and sex. These are shown below along with the expectations that are based on the five-year trend after
adjusting for seasonality.

These data are as of August 17, 2022 and exclude deaths that occurred after July 2, 2022. Figure 1 shows
that, for most months, the total A/E ratio is much greater than 100%, while the A/E ratio excluding COVID19 deaths is also greater than 100% by a few percent.

Author(s): Rick Leavitt, ASA, MAAA

Publication Date: August 2022

Publication Site: Society of Actuaries Research Institute

5 Worst States for Working-Age Death Increases in July

Link: https://www.thinkadvisor.com/2022/09/12/5-worst-states-for-working-age-death-increases-in-july/

Graphic:

Excerpt:

Early government mortality numbers show that the number of U.S. deaths has stayed very high this summer, both for members of the general population and for working-age people.

For all U.S. residents, for the period from July 3 through Aug. 27, the number of deaths recorded in the U.S. Centers for Disease Control and Prevention’s FluView reports was 426,881, according to the report released Friday, which included data sent to the CDC by Sept. 3.

The “all cause” total for the general population was down just 0.8% from the total for the comparable period in 2021, and it was 22% higher than the total for the comparable period in 2019, before the COVID-19 pandemic began.

For U.S. residents ages 25 through 64, the all-cause death total during that same period was 113,665, according to early, weighted data in the CDC’s Weekly Counts of Deaths by Jurisdiction and Age reports, as of Sept. 8.

Author(s): Allison Bell

Publication Date: 12 Sept 2022

Publication Site: Think Advisor

World Suicide Prevention Day: U.S. Suicide Trend Update through 2021

Link: https://marypatcampbell.substack.com/p/world-suicide-prevention-day-us-suicide

Graphic:

Excerpt:

In updating the 2021 numbers, there is some bad news: while suicide rates had decreased in 2020, in 2021 they increased to continue a worrying trend:

The increase in 2021 brought the age-adjusted death rate back to a level close to the peak, which was in 2018.

As noted on the graph, the cumulative increase in the age-adjusted death rate from the minimum in 2000 to the current levels has been 35%. This is very worrying.

I could have exaggerated this trend by starting my vertical scale at 10 instead of 0, but I think it’s obvious enough the trend is bad.

I don’t need to exaggerate.

Author(s): Mary Pat Campbell

Publication Date: 10 Sep 2022

Publication Site: STUMP on substack

Group Term Life – Results of 2021 U.S. Market Survey

Link: https://www.genre.com/knowledge/publications/2022/june/surveylhgtlsum2206-en

Graphic:

Excerpt:

Gen Re is pleased to share the results from our latest U.S. Group Term Life Market Survey, an industry benchmarking survey covering the Group Term Life (GTL) and AD&D industry. The survey tracks sales and in‑force results as well as lapse rate and employee-paid data.

Twenty-one of the 29 companies participating in the 2021 survey have provided Group Term Life data over the past 10 survey years.

Twenty-nine companies provided GTL results for 2021. Twenty-seven provided AD&D results. On a combined basis, total GTL and AD&D in‑force premium reached $31.6 billion, with GTL representing the majority (94%) of the total. (Exhibit A)

For GTL in‑force premium, reported industry growth has ranged between 2% and 5% over the past 10 years. In 2021, in‑force premium grew by 6% compared to 2020.

After a five-year low of 1% growth in 2020, AD&D in‑force premium rose by 3% in 2021. (Exhibit B)

Author(s): Nicole Conti

Publication Date: 7 June 2022

Publication Site: Gen Re

Crash Curse: In New York City, traffic deaths are up as enforcement is down.

Link: https://www.city-journal.org/nyc-traffic-deaths-up-as-enforcement-is-down

Graphic:

Excerpt:

Since the Covid pandemic hit New York City in March 2020, traffic deaths have skyrocketed, just as they have across the country. Locally and nationally, these deaths have paralleled the same double-digit trajectory upward as homicides and drug-overdose deaths. In 2019, 220 New Yorkers died on city streets, near the record low of 206, set the year before. In 2021, 273 people died, a nearly one-quarter increase in two years. In 2022, as of late May, 93 people have died, down slightly from last year, but 12 percent above pre-Covid levels.

….

s in many areas of public safety and public health, New York City started the pandemic with an advantage. In 2019, the city’s 220 traffic deaths—whether people in cars, or pedestrians, or cyclists—represented a per-capita rate of about 2.6 per 100,000 residents, just a small fraction of the 11.1 per 100,000 killed nationwide. Among large, urbanized areas, New York stood out for safety, as well. In Miami-Dade County in 2019, for example, the rate was 11 per 100,000; metro Atlanta’s rate was similar. Even among denser northeastern and mid-Atlantic cities, which have long had lower traffic-death rates than the sprawling south and west, New York performed slightly better than Boston, with its 2.8 traffic deaths per 100,000, and much better than Philadelphia, with its 5.7 deaths per 100,000.

Pre-pandemic, New York’s falling traffic deaths made it a national outlier. Between 2011, when traffic deaths hit a modern low nationwide, and 2019, such fatalities across the country rose by 11.9 percent, to 36,355 annually. In Gotham over this period, by contrast, they fell 12 percent. The difference in pedestrian casualties was especially striking. Nationwide, pedestrian deaths began rising in 2010, after having fallen, reasonably steadily, for at least three decades. By 2019, annual pedestrian deaths had risen from their 2009 low by more than half. But in New York, pedestrian deaths fell by 21.5 percent over the same near-decade.

Author(s): Nicole Gelinas

Publication Date: Summer 2022

Publication Site: City Journal

Two Key Takeaways From The New CDC Life Expectancy Data

Link: https://www.forbes.com/sites/ebauer/2022/09/02/two-key-takeaways-from-the-new-cdc-life-expectancy-data/?sh=6ce149f31cfc

Excerpt:

To what extent, are these drops of life expectancy due to Covid-19, rather than other causes?

From 2019 to 2020, the CDC reports that 90% of the drop in Hispanic life expectancy was attributable to Covid; the corresponding rates were 68% for whites and 59% for blacks. (No breakdown was provided for the AIAN or Asian categories.) However, the CDC data splits its breakdowns into “contributions to decreases” and “contributions to increases” rather than overall net effect. Those readers who are used to looking at data and charts will expect a “waterfall” style chart; the CDC version is not this, and is not particularly helpful.

In any event, relative to the 2020 baseline, the further decreases in life expectancy during 2021 had multiple causes. Only among the White demographic group was Covid the cause of over half of the decline; unintentional injury (including overdoses) was the second-largest contributing factor and for the AIAN demographic group, worsening rates of death due to chronic liver disease and cirrhosis played almost as substantial a role.

And, finally, it is important to understand that the CDC data shows a continued improvement in life expectancy due to reductions in death due to such causes as influenza/pneumonia, COPD/emphysema, Alzheimer disease, diabetes, and perinatal conditions (infant deaths). In fact, strikingly, in 2021, heart disease was a contributor to increased life expectancy in the Black, Hispanic, and Asian demographic groups, but a contributor to decreased life expectancy for the White and AIAN groups.

Again, though, the way the CDC provides its information means that, when it comes down to it, there is much that is simply missing; we do not know the magnitude of the improvements in life expectancy due to these causes, just that it exists. It even seems likely, or at least possible, that some of the apparent improvement in mortality due to these factors was actually because deaths were actually recorded as Covid deaths instead (whether due to multiple causes of death or other reasons).

Author(s): Elizabeth Bauer

Publication Date: 2 Sept 2022

Publication Site: Forbes

COVID-19 and the Short-Term Impact on Future U.S. Mortality

Link: https://www.soa.org/resources/research-reports/2022/covid-19-short-term-impact-us-mort/

PDF of report: https://www.soa.org/4a28d8/globalassets/assets/files/resources/research-report/2022/covid-19-short-term-impact-us-mort-report.pdf

Graphic:

Excerpt:

Excess mortality is expected to occur for all years studied with amounts varying by year and age.
Although the largest mortality excess numbers for the U.S. general population are foreseen for
2022, excess mortality is expected to decline each year so that by 2030, excess mortality numbers
are nearing expected levels. For 2030, mortality is projected to be 2% higher than expected for all
ages except age 85. At this age, 2030 projected mortality is estimated to be 1% higher than
expected.

Based on the average of the participants, generally, the amount of mortality excess is anticipated to be highest at the younger ages. For example, for 2022, projected mortality is anticipated to be 14% higher
compared to expected levels for age 25, 13% higher for age 45, and 10% higher for ages 65 and 85.

Author(s): Ronora Stryker, ASA, MAAA

Publication Date: August 2022

Publication Site: Society of Actuaries

Non-COVID deaths are up a significant amount this year. What’s driving the increase?

Link: https://www.abc.net.au/news/2022-08-08/non-covid-deaths-are-up-a-significant-amount-this-year/101309930

Excerpt:

There were an additional 4,000 non-COVID deaths, or a five per cent increase, in the first four months this year, compared with the pre-pandemic average.

The director of the Mortality Data Centre at the Australian Bureau of Statistics, Lauren Moran, said among the additional 4,000 deaths, more people died of chronic diseases compared to similar periods prior to the pandemic.

“We can see that for dementia, there’s been around a 20 per cent increase this year of the total number of deaths when we compare it to prior years, and around 18 per cent higher than expected for diabetes,” she said.

Ms Moran said that while some of the increase could be put down to natural variation and increases with an ageing population, the deaths are statistically significant and confirm a trend that began late last year.

Author(s): Annie Guest

Publication Date: 8 Aug 2022

Publication Site: Australian Broadcasting Commission News

Excess mortality in England

Link: https://app.powerbi.com/view?r=eyJrIjoiYmUwNmFhMjYtNGZhYS00NDk2LWFlMTAtOTg0OGNhNmFiNGM0IiwidCI6ImVlNGUxNDk5LTRhMzUtNGIyZS1hZDQ3LTVmM2NmOWRlODY2NiIsImMiOjh9

Data download:

Graphic:

Excerpt:

The numbers of expected deaths are estimated using statistical models and based on previous 5 years’ (2015 to 2019) mortality rates. Weekly monitoring of excess mortality from all causes throughout the COVID-19 pandemic provides an objective and comparable measure of the scale of the pandemic [reference 1]. Measuring excess mortality from all causes, instead of focusing solely on mortality from COVID-19, overcomes the issues of variation in testing and differential coding of cause of death between individuals and over time [reference 1].


In the weekly reports, estimates of excess deaths are presented by week of registration at national and subnational level, for subgroups of the population (age groups, sex, deprivation groups, ethnic groups) and by cause of death and place of death.

Author(s): Office for Health Improvement and Disparities

Publication Date: accessed 10 Aug 2022

Publication Site: Public PowerBI dashboard